Examining the histopathology of ILM flap in macular holes

Examining the histopathology of ILM flap in macular holes
Leigh Spielberg
Leigh Spielberg
Published: Friday, September 8, 2017
Dr Ricarda Schumann, of the Ludwig-Maximillians University Hospital, Munich, Germany, shared the results of her research into the histopathology of the inner limiting membrane (ILM) flap in large, idiopathic, full-thickness macular holes at the 17th Annual EURETINA Congress in Barcelona, Spain. The goal was to analyse the cellular characteristics of the ILM in macular hole cases. This is important, as a fragment of the ILM, referred to as the “ILM flap”, is placed into or over the fovea in large macular holes, which are less likely to close without a flap. As such, studying the cell distribution and characteristics of premacular cell proliferation in surgically excised ILM specimens might give insight into how an ILM flap assists in the holes’ closure. The specimens were studied using interference, phase-contrast, immunofluorescence and transmission electron microscopy. A very broad variety of cell density was discovered, including hyalocytes, myofibroblasts and native vitreous collagen. These cells were all found on the ILM’s vitreal side. However, not only cells were found. “This was the first study to demonstrate the presence of neurotrophic factors in the ILM,” said Dr Schumann. These included glial cell-derived neurotrophic factor and ciliary neurotrophic factor, both of which showed high levels of immunoreactivity. Dr Schumann raised the question of whether there might be a possible role for premacular cells and neurotrophic factors in the rehabilitation of retinal architecture and function.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...